Evidence suggests that cancer-associated fibroblasts (CAFs), derived from hepatic stellate cells (HSCs), facilitate the growth of intrahepatic cholangiocarcinoma by releasing hepatocyte growth factor via direct interaction in the HSC-CAFa-tumor pathway, thus activating the tumor-expressed MET pathway (58). Here, MET is linked to cholangiocarcinoma.